2
Roll Calls
Providing for consideration of the bill (H.R. 1629) to amend the Federal Food, Drug, and Cosmetic Act with respect to limitations on exclusive approval or licensure of orphan drugs, and for other purposes; providing for consideration of the resolution (H. Res. 275) condemning the horrific shootings in Atlanta, Georgia, on March 16, 2021, and reaffirming the House of Representative's commitment to combating hate, bigotry, and violence against the Asian-American and Pacific Islander community; and for other purposes.
Policy Area: Congress
Sponsor: Rep. Scanlon, Mary Gay [D-PA-5] (D-PA)
Latest Action (2021-05-18): Motion to reconsider laid on the table Agreed to without objection.
This resolution sets forth the rule for consideration of H.R. 1629 (Fairness in Orphan Drug Exclusivity Act) and H. Res. 275 (condemning the acts of gun violence that led to the tragic loss of eight lives in Georgia on March 16, 2021). In addition, the resolution adopts H. Res. 398 (recognizing the forthcoming centennial of the 1921 Tulsa Race Massacre and reaffirming the House of Representative's opposition to violence against Asian Americans). The resolution also extends through July 1, 2021, the waiver of certain procedural requirements regarding journal approval, adjournment, suspension of the rules, and consideration of certain resolutions. Finally, the resolution authorizes the Speaker of the House at any time through the legislative day of Thursday, May 20, 2021, to suspend the rules on multiple measures that were the object of a motion to suspend the rules on the legislative day of May 17, 2021, or May 18, 2021.
Subjects: House of Representatives, Legislative rules and procedure
Filter by Yea, Nay, or Absent
How members voted on HRES403. 580 total positions across all roll calls for this bill.
| Member | Date | Question | Vote | Result |
|---|---|---|---|---|
| Robert B. Aderholt (R-Alabama) | 2021-05-18 | Yea-and-Nay | Nay | Passed |
| Jake Auchincloss (D-Massachusetts) | 2021-05-18 | Yea-and-Nay | Yea | Passed |
| Mark E. Amodei (R-Nevada) | 2021-05-18 | Yea-and-Nay | Nay | Passed |
| Alma S. Adams (D-North Carolina) | 2021-05-18 | Yea-and-Nay | Yea | Passed |
| Pete Aguilar (D-California) | 2021-05-18 | Yea-and-Nay | Yea | Passed |
| Rick W. Allen (R-Georgia) | 2021-05-18 | Yea-and-Nay | Nay | Passed |
| Jodey C. Arrington (R-Texas) | 2021-05-18 | Yea-and-Nay | Nay | Passed |
| Sanford D. Bishop (D-Georgia) | 2021-05-18 | Yea-and-Nay | Yea | Passed |
| Cliff Bentz (R-Oregon) | 2021-05-18 | Yea-and-Nay | Nay | Passed |
| Stephanie I. Bice (R-Oklahoma) | 2021-05-18 | Yea-and-Nay | Nay | Passed |
| Lauren Boebert (R-Colorado) | 2021-05-18 | Yea-and-Nay | Nay | Passed |
| Gus M. Bilirakis (R-Florida) | 2021-05-18 | Yea-and-Nay | Nay | Passed |
| Vern Buchanan (R-Florida) | 2021-05-18 | Yea-and-Nay | Nay | Passed |
| Suzanne Bonamici (D-Oregon) | 2021-05-18 | Yea-and-Nay | Yea | Passed |
| Joyce Beatty (D-Ohio) | 2021-05-18 | Yea-and-Nay | Yea | Passed |
| Andy Barr (R-Kentucky) | 2021-05-18 | Yea-and-Nay | Nay | Passed |
| Julia Brownley (D-California) | 2021-05-18 | Yea-and-Nay | Yea | Passed |
| Ami Bera (D-California) | 2021-05-18 | Yea-and-Nay | Yea | Passed |
| Brian Babin (R-Texas) | 2021-05-18 | Yea-and-Nay | Nay | Passed |
| Donald S. Beyer (D-Virginia) | 2021-05-18 | Yea-and-Nay | Yea | Passed |
| Mike Bost (R-Illinois) | 2021-05-18 | Yea-and-Nay | Nay | Passed |
| Brendan F. Boyle (D-Pennsylvania) | 2021-05-18 | Yea-and-Nay | Yea | Passed |
| Don Bacon (R-Nebraska) | 2021-05-18 | Yea-and-Nay | Nay | Passed |
| Jim Banks (R-Indiana) | 2021-05-18 | Yea-and-Nay | Nay | Passed |
| Nanette Diaz Barragán (D-California) | 2021-05-18 | Yea-and-Nay | Not Voting | Passed |
| Jack Bergman (R-Michigan) | 2021-05-18 | Yea-and-Nay | Nay | Passed |
| Andy Biggs (R-Arizona) | 2021-05-18 | Yea-and-Nay | Nay | Passed |
| Lisa Blunt Rochester (D-Delaware) | 2021-05-18 | Yea-and-Nay | Yea | Passed |
| Ted Budd (R-North Carolina) | 2021-05-18 | Yea-and-Nay | Nay | Passed |
| Troy Balderson (R-Ohio) | 2021-05-18 | Yea-and-Nay | Nay | Passed |
| James R. Baird (R-Indiana) | 2021-05-18 | Yea-and-Nay | Nay | Passed |
| Tim Burchett (R-Tennessee) | 2021-05-18 | Yea-and-Nay | Nay | Passed |
| Ken Calvert (R-California) | 2021-05-18 | Yea-and-Nay | Nay | Passed |
| James E. Clyburn (D-South Carolina) | 2021-05-18 | Yea-and-Nay | Yea | Passed |
| Kat Cammack (R-Florida) | 2021-05-18 | Yea-and-Nay | Nay | Passed |
| John R. Carter (R-Texas) | 2021-05-18 | Yea-and-Nay | Nay | Passed |
| Tom Cole (R-Oklahoma) | 2021-05-18 | Yea-and-Nay | Nay | Passed |
| Ed Case (D-Hawaii) | 2021-05-18 | Yea-and-Nay | Yea | Passed |
| Jim Costa (D-California) | 2021-05-18 | Yea-and-Nay | Not Voting | Passed |
| Emanuel Cleaver (D-Missouri) | 2021-05-18 | Yea-and-Nay | Yea | Passed |
| Henry Cuellar (D-Texas) | 2021-05-18 | Yea-and-Nay | Yea | Passed |
| Kathy Castor (D-Florida) | 2021-05-18 | Yea-and-Nay | Yea | Passed |
| Yvette D. Clarke (D-New York) | 2021-05-18 | Yea-and-Nay | Yea | Passed |
| Steve Cohen (D-Tennessee) | 2021-05-18 | Yea-and-Nay | Yea | Passed |
| Joe Courtney (D-Connecticut) | 2021-05-18 | Yea-and-Nay | Yea | Passed |
| André Carson (D-Indiana) | 2021-05-18 | Yea-and-Nay | Yea | Passed |
| Judy Chu (D-California) | 2021-05-18 | Yea-and-Nay | Yea | Passed |
| Eric A. "Rick" Crawford (R-Arkansas) | 2021-05-18 | Yea-and-Nay | Nay | Passed |
| Joaquin Castro (D-Texas) | 2021-05-18 | Yea-and-Nay | Yea | Passed |
| Katherine M. Clark (D-Massachusetts) | 2021-05-18 | Yea-and-Nay | Yea | Passed |
Showing 50 of 580 positions. JavaScript-enabled view supports filter by Yea/Nay/Absent and pagination.
Interactive features require JavaScript. Static data shown above.
HRES403 is the Providing for consideration of the bill (H.R. 1629) to amend the Federal Food, Drug, and Cosmetic Act with respect to limitations on exclusive approval or licensure of orphan drugs, and for other purposes; providing for consideration of the resolution (H. Res. 275) condemning the horrific shootings in Atlanta, Georgia, on March 16, 2021, and reaffirming the House of Representative’s commitment to combating hate, bigotry, and violence against the Asian-American and Pacific Islander community; and for other purposes., introduced in the House of the 119th U.S. Congress by Rep. Scanlon, Mary Gay [D-PA-5] (D-PA). This resolution sets forth the rule for consideration of H.R. 1629 (Fairness in Orphan Drug Exclusivity Act) and H.
HRES403 was sponsored by Rep. Scanlon, Mary Gay [D-PA-5] (D-PA). Cosponsors and roll-call positions are listed on this page.
As of 2021-05-18, HRES403 Motion to reconsider laid on the table Agreed to without objection..
HRES403 has had 2 roll-call votes on record. The most recent: 2021-05-18 — Yea-and-Nay (Passed).
HRES403 is categorized under "Congress." Browse other bills in this area at /topic-congress/.
Each member’s vote is shown on this page, with party affiliation, state, and the official vote question. Click any member to see their full voting record.